Cerebrolysin was administered to 38 patients with small hypertensive supratentorial intracranial hemorrhages. Cerebrolysin was used intravenous in drops in dosage of 30 ml during 14 days. High effectiveness and good tolerability of the treatment was shown. In the end of treatment, groups receiving cerebrolysin or placebo were statistically significant differed by the total NIHSS score, Bartel index and the Rankin's modified scale. Moreover, a trend to the decrease of intracranial hemorrhage volume was observed in patients treated with cerebrolysin.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hypertensive supratentorial
8
supratentorial intracranial
8
intracranial hemorrhages
8
[effectiveness cerebrolysin
4
cerebrolysin hypertensive
4
hemorrhages randomized
4
randomized triple
4
triple blind
4
blind placebo-controled
4
placebo-controled study]
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!